Theresa A. Deisher

About

Dr. Deisher is a world renowned scientist in the field of adult stem cell therapies and regenerative medicine. Dr. Deisher has over 47 patents in her name, which have generated up to $200 million in licensing revenue and are potentially worth more than $100 million in future royalty payments. Several more of her inventions are currently in clinical trials. Prior to founding AVM, Dr. Deisher’s previous assignments included: Vice President at Cellcyte Genetics (Kirkland, WA); Principal Scientist at Amgen (Seattle, WA); Sr. Staff Scientist, Vascular Biology at Immunex (Seattle, WA); Sr. Scientist, Cardiovascular Biology at ZymoGenetics (Seattle, WA); and, Research Scientist at Repligen (Waltham, MA). She was the first person world-wide to identify and patent stem cells from the adult heart, including what are now called “very small embryonic-like stem cells” (VSELS), and also is a patented inventor of the most potent mesenchymal growth factor ever identified, as well as of the use of cy

Investment Focus

Location

Seattle, US